175 related articles for article (PubMed ID: 37487008)
1. Single-cell transcriptomics reveals the drivers and therapeutic targets of lymph node metastasis in lung adenocarcinoma.
Ji X; Wang Z; Wang G; Tang L; Han Z
Aging (Albany NY); 2023 Jul; 15(14):7023-7037. PubMed ID: 37487008
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma.
Wang Z; Wang Y; Chang M; Wang Y; Liu P; Wu J; Wang G; Tang X; Hui X; Liu P; Guo X; Xing B; Wang Y; Han Z; Ma W
Neuro Oncol; 2023 Jul; 25(7):1262-1274. PubMed ID: 36656750
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a Lymph Node Metastasis-Associated Prognostic Signature for Lung Adenocarcinoma.
Yu J; Li G; Tian Y; Huo S
Genet Res (Camb); 2023; 2023():6585109. PubMed ID: 36793937
[TBL] [Abstract][Full Text] [Related]
4. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X
Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer.
Brennan K; Espín-Pérez A; Chang S; Bedi N; Saumyaa S; Shin JH; Plevritis SK; Gevaert O; Sunwoo JB; Gentles AJ
Genome Med; 2023 Nov; 15(1):98. PubMed ID: 37978395
[TBL] [Abstract][Full Text] [Related]
6. Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.
Zhou Y; Shi X; Chen H; Mao B; Song X; Gao L; Zhang J; Yang Y; Zhang H; Wang G; Zhuang W
Biomed Res Int; 2021; 2021():5557649. PubMed ID: 34337026
[TBL] [Abstract][Full Text] [Related]
7. A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma.
Cen SY; Fu KY; Shi Y; Jiang HL; Shou JW; You LK; Han WD; Pan HM; Liu Z
Math Biosci Eng; 2020 Feb; 17(3):2557-2568. PubMed ID: 32233554
[No Abstract] [Full Text] [Related]
8. Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma.
Li W; Ou D; Zhang J; Ye M
Comput Math Methods Med; 2022; 2022():3887857. PubMed ID: 35836921
[TBL] [Abstract][Full Text] [Related]
9. Nomograms for intraoperative prediction of lymph node metastasis in clinical stage IA lung adenocarcinoma.
Li F; Zhai S; Fu L; Yang L; Mao Y
Cancer Med; 2023 Jul; 12(13):14360-14374. PubMed ID: 37212495
[TBL] [Abstract][Full Text] [Related]
10. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
[TBL] [Abstract][Full Text] [Related]
12. Genomic and immunogenomic analysis of three prognostic signature genes in LUAD.
Feng HM; Zhao Y; Yan WJ; Li B
BMC Bioinformatics; 2023 Jan; 24(1):19. PubMed ID: 36650426
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
14. Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.
Zhang P; Liu J; Pei S; Wu D; Xie J; Liu J; Li J
Front Immunol; 2023; 14():1189520. PubMed ID: 37256127
[TBL] [Abstract][Full Text] [Related]
15. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
[TBL] [Abstract][Full Text] [Related]
16. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
He J; Zhang W; Li F; Yu Y
Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
[TBL] [Abstract][Full Text] [Related]
17. Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma.
Ren S; Wang J; Xu A; Bao J; Cho WC; Zhu J; Shen J
Cell Oncol (Dordr); 2022 Feb; 45(1):57-67. PubMed ID: 35025009
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
19. A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis.
Wang Y; Zhang Q; Gao Z; Xin S; Zhao Y; Zhang K; Shi R; Bao X
Cancer Cell Int; 2019; 19():100. PubMed ID: 31015800
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the evolution trajectory and immune profiling of new histologic patterns in lung adenocarcinoma.
Song M; Xie H; Liu W; Zhao M; Deng Z; Zhang L; Liu H; Huang Y; Li H; Ren Y; Chen C
J Gene Med; 2022 Nov; 24(11):e3455. PubMed ID: 36194517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
